Best Biotech Stocks

Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?

Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again on the move...

13h ago

MRNA

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s...

15h ago

REGN

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its...

17h ago

U.S. FDA Approves Amgen’s (NASDAQ:AMGN) Imdelltra

The U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) Imdelltra (tarlatamab-dlle) therapy for extensive-stage small cell...

22h ago

Amgen says FDA approves Imdelltra

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA (tarlatamab-dlle) for the treatment of...

1d ago

Galapagos creates new subscription rights plans

On May 16, the Board of Directors of Galapagos (GLPG) approved “Subscription Right Plan 2024 BE”, intended for...

2d ago

GILD

GLPG

FDA grants accelerated approval for Amgen’s tarlatamab-dlle

The Food and Drug Administration granted accelerated approval to tarlatamab-dlle, or Imdelltra, from Amgen for extensive stage small...

2d ago

Biogen says won’t exercise option to license and lead development of BIIB121

Biogen stated: “In addition to discontinuing development of BIIB105, an investigational antisense oligonucleotide, or ASO, for amyotrophic lateral...

2d ago

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

CAMBRIDGE, Mass. and CARLSBAD, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and...

2d ago

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

Amgen

Buy

Assigned

2024-05-17

Biogen

Hold

Assigned

2024-05-17

REGN

Regeneron

Buy

Assigned

2024-05-15

MRNA

Moderna

Buy

Assigned

2024-05-15

ILMN

Illumina

Hold

Reiterated

2024-05-14

BioNTech SE

Hold

Initiated

2024-05-13

VRTX

Vertex Pharmaceuticals

Buy

Assigned

2024-05-10

IQV

IQVIA Holdings

Buy

Reiterated

2024-05-08

GILD

Gilead Sciences

Buy

Reiterated

2024-05-01

Biogen

Buy

Reiterated

2024-05-16

All Ratings >

Most Recent Earnings of Biotech Stocks

GILD

Gilead Sciences

Apr 25, 2024

Mar 01, 2024

-1.49 / -1.32

1.34

Amgen

May 02, 2024

Mar 01, 2024

3.88 / 3.96

VRTX

Vertex Pharmaceuticals

May 06, 2024

Mar 01, 2024

4.07 / 4.76

3.89

Biogen

Apr 24, 2024

Mar 01, 2024

3.47 / 3.67

4.02

ILMN

Illumina

May 02, 2024

Mar 01, 2024

0.04 / 0.09

0.32

REGN

Regeneron

May 02, 2024

Mar 01, 2024

10.17 / 9.55

10.24

MRNA

Moderna

May 02, 2024

Mar 01, 2024

-3.56 / -3.07

-3.62

IQV

IQVIA Holdings

May 02, 2024

Mar 01, 2024

2.49 / 2.54

2.43

BioNTech SE

May 06, 2024

Mar 01, 2024

-1.35 / -1.42

-0.79

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

Biogen - Strong Buy, based on 24 analyst ratings, 18 Buy, 6 Hold, and 0 Sell.

Regeneron - Strong Buy, based on 20 analyst ratings, 16 Buy, 3 Hold, and 1 Sell.

IQVIA Holdings - Strong Buy, based on 13 analyst ratings, 12 Buy, 1 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $67.72, and its average 12-month price target is $81.30.

Amgen's stock price is currently $312.47, and its average 12-month price target is $322.75.

Vertex Pharmaceuticals's stock price is currently $445.21, and its average 12-month price target is $457.73.

Biogen's stock price is currently $230.57, and its average 12-month price target is $287.27.

Illumina's stock price is currently $111.07, and its average 12-month price target is $157.25.

Regeneron's stock price is currently $982.29, and its average 12-month price target is $1,058.17.

Moderna's stock price is currently $132.90, and its average 12-month price target is $130.29.

IQVIA Holdings's stock price is currently $231.18, and its average 12-month price target is $276.75.

BioNTech SE's stock price is currently $90.61, and its average 12-month price target is $110.58.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.77 which represents an annual dividend yield of 4.51%. Gilead Sciences's next Ex-dividend date is June 14, 2024 and its next payout date is June 27, 2024.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.

Latest News

Microsoft (NASDAQ:MSFT) Challenges Nvidia with AMD AI Chips on Azure

AMD

MSFT

Camping World Holdings (NYSE:CWH) Prepares for an RV Market Recovery

CWH

Cleveland-Cliffs (NYSE:CLF) CEO Suggests U.S. Steel Deal Will Be Blocked

CLF

Nvidia Stock (NASDAQ:NVDA): Is It a Buy at 71.3x Earnings?

AMD

AMZN

Stock Market News Today, 5/17/24 – Indices Finish Mixed amid Rising Yields

NDX

SPX

Analyst Approval Gives Pinduoduo (NASDAQ:PDD) a Leg Up

PDD

Stagwell (NASDAQ:STGW) Rides the Digital Advertising Wave

STGW

Apple (NASDAQ:AAPL) Working on Thinner iPhone. Investors Cheer.

DIS

AAPL

Ingevity (NYSE:NGVT): Profiting from the Green Transition

NGVT

Netflix (NASDAQ:NFLX) Proves It’s Beyond Just Movies

NFLX

Cathie Wood Abandons Twilio Stock (NASDAQ:TWLO): What to Make of It

ARKF

ARKK

GBP-USD Forecast: Trading Goldmine or Minefield?

New Intel (NASDAQ:INTC) Leaks Suggest New Chips Sooner than Later

INTC

EUR-USD Forecast: A Potential Long-Term Headache